Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hemogenyx Pharmaceuticals PLC

5HU
Current price
0.0095 EUR +0.0005 EUR (+5.56%)
Last closed 1.35 GBX
ISIN GB00BYX3WZ24
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 20 073 608 GBX
Yield for 12 month -34.85 %
1Y
3Y
5Y
10Y
15Y
5HU
21.11.2021 - 28.11.2021

Hemogenyx Pharmaceuticals Plc, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood cancer. The company's lead product candidate is the HEMO-CAR-T therapy for the treatment and potential cure for relapsed and/or refractory acute myeloid leukemia. It also develops chimeric bait receptor to treat COVID-19 virus, as well as to treat brain cancers and/or certain neurodegenerative diseases; and CDX bi-specific antibody which eliminates hematopoietic stem cells/hematopoietic progenitors in a patient using bi-specific antibodies; and cell therapy products for bone marrow/hematopoietic stem cell transplantation. Hemogenyx Pharmaceuticals Plc was incorporated in 2013 and is headquartered in London, the United Kingdom. Address: 60 Gracechurch Street, London, United Kingdom, EC3V 0HR

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-64 827 921 GBX

Last Year

-261 022 377 GBX

Current Quarter

-32 297 982 GBX

Last Quarter

Key Figures 5HU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 816 339 GBX
Operating Margin TTM
PE Ratio
Return On Assets TTM -37.79 %
PEG Ratio
Return On Equity TTM -155.97 %
Wall Street Target Price
Revenue TTM
Book Value 0.002 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.01 GBX
Diluted Eps TTM -0.01 GBX
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics 5HU

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History 5HU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation 5HU

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.6239
Price Book MRQ 6.5254

Financials 5HU

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 5HU

For 52 weeks

1.09 GBX 4.51 GBX
50 Day MA 1.4 GBX
Shares Short Prior Month
200 Day MA 1.74 GBX
Short Ratio
Shares Short
Short Percent